Tags: M3 Biotechnology

blog

Top Five Alzheimer’s Advances in 2017

Our top five advances in 2017 spotlight the substantial progress we have made toward conquering Alzheimer’s and other neurodegenerative diseases.

announcements

Sharon Sager of UBS Honored for Support of Alzheimer's Research

Sharon Sager from UBS received The Charles Evans Award at our Eighth Annual Fall Symposium & Luncheon. The event raised over $1.2 million.

blog

Driving Innovation in Alzheimer's Therapies

At our 18th Annual Conference on Alzheimer’s Drug Discovery in Jersey City, the impact of our approach will take center stage.

announcements

ADDF Funding Advances M3 Biotechnology Toward Clinical Trials

Our new investment in M3 Biotechnology is advancing its drug program toward clinical trials

announcements

$4 Million in New Grants Support Several First-in-Class Dementia Treatments

We recently awarded eight new grants totaling over $4 million to advance treatments for Alzheimer’s and related dementias. Several of the awards support new approaches to treating these diseases.